¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Middle Eastern studies."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • middle phalanx
    Áß°£¸¶µð»À, ÁßÁö°ñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ear, radical operation of middle
    ÁßÀ̱ÙÄ¡¼ö¼ú
  • fascia of middle cerebellar peduncle
  • ganglion, middle cervical
    Áß°æ½Å°æÀý, Áß°£¸ñ½Å°æÀý
  • groove for middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ°í¶û
  • groove for middle temporal artery
    Áß°£Ãø µÎµ¿¸Æ°í¶û, ÁßÃøµÎµ¿¸Æ±¸(ñéö°ÔéÔÑØæÏµ).
  • groove for middle temporal artery
    Áß°£Ãø µÎµ¿¸Æ°í¶û, ÁßÃøµÎµ¿¸Æ__ñéö°ÔéÔÑØæÏµ).
  • groove for middle temporal artery
    Áß°£°üÀÚµ¿¸Æ°í¶û
  • lateral segmental branch artery of middle lobe artery<³ª> ramus lateralis rami lobi medii
    Áß°£¿±µ¿¸ÆÀÇ ¿ÜÃøÁö.
  • lateral striate artery of middle cerebral artery<³ª> rami striati artery cerebri mediae
    (Áß°£´ë³úµ¿¸ÆÀÇ) ¼±Á¶Ã¼Áö.
  • meatus, middle (of nose)
    Áߺñµµ
  • meatus, middle nasal
    Áߺñµµ
  • medi scalenus =middle scalenem
    Áß°£°æ Ãß´Á°ñ±Ù, Á߻簢±Ù.
  • medial segmental branch of middle lobe artery
    Áß°£¿±µ¿¸ÆÀÇ ³»Ãø°¡Áö, Áß¿±µ¿¸ÆÀÇ ³»Ãø?
  • meningeal branch (middle meningeal branch)
    (Áß°£)³ú¸·°¡Áö
  • middle
    Áß°£
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Middle temporal gyrus
    Áß°£°üÀÚÀ̶û
    [¿¾ ¿ë¾î] ÁßÃøµÎȸ
  • Middle temporal vein
    Áß°£°üÀÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁßÃøµÎÁ¤¸Æ
  • Middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ
    [¿¾ ¿ë¾î] Á߰渷µ¿¸Æ
  • Groove for middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ°í¶û
    [¿¾ ¿ë¾î] Á߰渷µ¿¸Æ±¸
  • Middle meningeal veins
    Áß°£³ú¸·Á¤¸Æ
    [¿¾ ¿ë¾î] Á߰渷Á¤¸Æ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß°£´ë³úµ¿¸Æ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß´ë³úµ¿¸Æ
  • Middle phalanges
    Áß°£¸¶µð»À
    [¿¾ ¿ë¾î] ÁßÀý°ñ
  • Middle coat
    Áß°£¸·
    [¿¾ ¿ë¾î] Á߸·
  • Middle cranial fossa
    Áß°£¸Ó¸®»À¿ì¹¬
    [¿¾ ¿ë¾î] Áߵΰ³¿Í
  • Middle articular surface for talus
    Áß°£¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] Á߰Űñ°üÀý¸é
  • Middle cervical ganglion
    Áß°£¸ñ½Å°æÀý
    [¿¾ ¿ë¾î] Áß°æ½Å°æÀý
  • Middle cervical cardiac nerve
    Áß°£¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Áß°æ½ÉÀå½Å°æ
  • Middle genicular artery
    Áß°£¹«¸­µ¿¸Æ
    [¿¾ ¿ë¾î] Áß½½µ¿¸Æ
  • Middle calcaneal articular surface
    Áß°£¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÁßÁ¾°ñ°üÀý¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECOG Eastern Cooperative Oncology Group
EEEV eastern equine encephalomyelitis virus
FETE Far Eastern tick-borne encephalitis
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
CES-D Center for Epidemiological Studies of Depression [scale]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EEE Eastern equine encephalomyelitis
SEOPF South Eastern Organ Procurement Foundation
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • middle meningeal vein
    Á߰ݸ· Á¤¸Æ, Áß°£ ³ú¸· Á¤¸Æ
    Á߰渷 µ¿¸ÆÀÇ ¹ÝÇà Á¤¸Æ. À͵¹±Ù Á¤¸ÆÃÑÀ¸·Î °³±¸ÇÑ´Ù.
  • middle nasal concha
    Áߺñ°©°³
  • middle otitis
    ÁßÀÌ¿°
  • middle palatal bar
    Áß¾Ó ±¸°³°£
  • middle rectal vein
    Áß Á÷Àå Á¤¸Æ, Áß°£ Á÷Àå Á¤¸Æ, Áß°£ °ðâÀÚ Á¤¸Æ
    Á÷Àå Á¤¸ÆÃÑ¿¡¼­ Ç÷¾×À» ¹Þ¾Æ, ³»Àå°ñ Á¤¸Æ ¹× »óÁ÷Àå Á¤¸ÆÀ¸·Î ¿î¹ÝÇÏ´Â Á¤¸Æ.
  • middle temporal artery
    Áß ÃøµÎ µ¿¸Æ, Áß°£ ÃøµÎ µ¿¸Æ, Áß°£ °üÀÚ µ¿¸Æ
    ÃøµÎ³»±Ù¿¡¼­ ½ÃÀÛÇÏ¿© ±Ù¸· ¾Æ·¡¸¦ °ü°ñ±îÁö ÇÏÇàÇϸç, À̰÷¿¡¼­ ºÐÁöÇÏ¿© ̵̿µÎ µ¿¸Æ°ú ¸¸³­´Ù.
  • middle third
    Áß¾Ó 1/3
    Ä¡¾Æ¸¦ 3µîºÐÇÏ¿´À» ¶§ Áß¾Ó ºÎÀ§¸¦ ÀǹÌÇÑ´Ù.
  • middle trace
    Áß¾Ó °æ·Î
  • middle turn
    Áß°£ ȸÀü
  • posterior, middle superior alveolar nerve plexus
    ÈÄÁß»óÄ¡Á¶ ½Å°æÃÑ
  • right middle lobe
    ¿À¸¥ Áß°£¿±, ¿ìÁß¿±
  • superficial middle cerebral vein
    ¾èÀº Áß°£ ´ë³ú Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
organizational case studies Descriptions and evaluations of specific health care organizations.
(12 Dec 1998)
time and motion studies The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task.
(12 Dec 1998)
electrophysiological studies <investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined. This test is often performed in those where a life-threatening cardiac arrhythmia is a problem.
The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
Acronym: EPS
(14 Mar 2000)
epidemiologic studies Studies designed to examine associations, commonly, hypothesised causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are case-control studies, cohort studies, and cross-sectional studies.
(12 Dec 1998)
evaluation studies Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, clinical trials, drug evaluation, and drug screening are available.
(12 Dec 1998)
twin studies Methods of detecting genetic aetiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilised ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies.
(12 Dec 1998)
feasibility studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.
(12 Dec 1998)
follow-up studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
(12 Dec 1998)
longitudinal studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
(12 Dec 1998)
accessory meningeal branch of middle meningeal artery <anatomy, artery> A branch of either the middle meningeal or maxillary artery in the infratemporal fossa and passing superiorly through the foramen ovale to supply the trigeminal ganglion, dura mater and inner table of bone.
Synonym: ramus meningeus accessorius arteriae meningeae mediae.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eastern hemisphere
    µ¿¹æ±³È¸
  • middle
    ÇÑ °¡¿îµ¥ÀÇ,°¡¿îµ¥
  • Middle Dutch
    Áß¼¼(Áß±â) ³×´ú¶õµå ¸»
  • Middle Empire
    =MIDDLE KINGDOM 2
  • Middle English
    Áß¼¼(Áß±â) ¿µ¾î(¾à 1100-1500³â)
  • Middle Flemish
    Áß¼¼(Áß±â) Çöûµå¸£¸»(14-16¼¼±â)
  • Middle French
    Áß¼¼(Áß±â) ÇÁ¶û½º¾î(14-16¼¼±â)
  • Middle Greek
    Áß¼¼(Áß±â) ±×¸®½º¾î
  • Middle High German
    Áß¼¼(Áß±â) °íÁö µ¶ÀϾî(12-15¼¼±â)
  • Middle Low German
    Áß¼¼(Áß±â) ÀúÁö µ¶ÀϾî(12-15¼¼±â)
  • Middle West
    ¹Ì±¹ Áß¼­ºÎ
  • middle
    Áß¾Ó(ÀÇ);Áß°£(ÀÇ);ÁߺÎ(ÀÇ);Á߸í»ç(»ç¶÷ÀÇ)¸öÅë;Ç㸮
  • middle C
    Áß¾Ó ´Ù(1Á¡ ´Ù,ÀÌ À½À» ³»´Â °Ç¹Ý)
  • middle age
    Áß³â(40,60)
  • middle ages
    Áß¼¼(±â)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á